表紙
市場調查報告書
商品編碼
391472

隱形眼鏡的全球市場:成長,趨勢,預測(2019∼2024年)

Contact Lenses Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球隱形眼鏡市場,由於眼科疾病的罹患率上升,可支配所得的上升等而成長。隱形眼鏡用於替代較難管理的眼鏡,過去10年進行大幅技術創新。

本報告提供全球隱形眼鏡市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場定義趨勢

  • 市場概要
  • 推動市場的要素
    • 眼科疾病的罹患率上升
    • 對美容的傾倒
    • 可支配所得的上升
  • 阻礙市場的要素
    • 替代技術的利用可能性
    • 鏡片相關併發症
  • 產業的魅力度:波特五力分析

第5章 市場區隔

  • 各產品
    • 軟式隱形眼鏡
    • 混合隱形眼鏡
    • 氣體滲透性隱形眼鏡
    • 其他
  • 各使用
    • 矯正用
    • 治療用
    • 美容用
    • 義肢用
  • 各種模式
    • 傳統
    • 拋棄式
  • 各種設計
  • 各流通管道
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Staar Surgical
    • Novartis AG
    • Bausch Health Companies Inc.
    • Zeiss Group
    • The Cooper Companies
    • Essilor International SA
    • HOYA株式會社
    • Haohai Biological Technology
    • Johnson & Johnson Vision Care Inc..
    • SynergEyes Inc.

第7章 市場機會與未來趨勢

目錄
Product Code: 52931

The contact lenses market was valued at approximately USD 9,785 million in 2020, and it is expected to reach USD 12,995 million by 2026, registering a CAGR of nearly 5% during the forecast period, 2021-2026.

The impact of COVID-19 on the market growth was negative in 2020 due to fewer eye care consultations. Moreover, the market may prevail with the normal growth rate in the near future. For instance, as per the Centers for Disease Control and Prevention and the American Academy of Ophthalmology, it is estimated that there was a nearly 80% initial decrease in ophthalmology visits, and as of mid-June, there was still a cumulative decrease in ophthalmology visits of 40% in the United States.

The growth of the contact lens market is attributed to the rising prevalence of optical disorders, the rising tendency to improve aesthetics, and increasing disposable incomes. According to WHO, in 2019, it was estimated that around 2.2 billion people have vision impairment or blindness. Also, an emerging important cause of visual impairment in the developed regions of the world is uncorrected refractive errors. The rising geriatric population is further aggravating the prevalence of ophthalmic disorders; the leading causes of vision impairment are uncorrected refractive errors and cataracts, and most people with vision impairment are over the age of 50 years.

The field of optometry and optics has observed a significant increase in research and development activities related to the studied market. Spme of the recent advancements pertaining to the studied market such as the development of dynamic soft contact lenses with advanced technology have propelled the growth for contact lenses globally. For instance, in November 2018, IMEC entered into collaboration with SEED Co. Ltd, to develop a smart contact lens, that has components such as an LED light, an ultra-thin silicon microchip, and radio-frequency antenna for wireless energy transfer.

The increasing product launches and developments have increased the adoption of contact lenses. For instance, in March 2019, Alcon Vision LLC launched AcrySof IQ PanOptix Trifocal IOL in the United States, that can be used for intermediate, distance, and near vision. Additionally, the growing trend in the developments in contact lenses with drug-delivering capabilities are further expected to drive the market demand over the forecast period. However, factors such as availability of alternative techniques and complications associated with lenses are likely to hamper the market growth.

Key Market Trends

Corrective Contact Lenses are Expected to Exhibit a Significant Growth Rate over the Forecast Period

The outbreak of COVID-19 had an impact on the corrective lenses segment because eye care services were significantly reduced due to social distancing measures taken by governments across the globe. However, the ophthalmology practices are being continued with preventive measures. In August 2020, in India, the Ministry of Health and Family Welfare proposed guidelines on safe ophthalmology practices during the COVID-19 scenario, such as eye-care facilities should ensure that tele-counseling and teleconsultation should be promoted to reduce patient visits or/and appointment system can be followed to call patients needing examination/eye procedures/investigations.

Corrective lenses are lenses made specifically to match the wearer's vision defects. The purpose of the corrective lens is to improve or correct the vision of people with farsightedness (hyperopia), nearsightedness (myopia), presbyopia, and astigmatism.

The rising product launches have increased the adoption of corrective contact lenses. In November 2019, the US FDA approved Coopervision Inc.'s Misight 1 day, the first corrective contact lens designed to slow the progression of myopia or near-sightedness in children. The disposable, single-use, soft contact lens is made for children diagnosed with myopia and who begin Misight treatment at an early age.

With available vision correction solutions and rising awareness about vision impairment conditions, the demand for these devices is increasing. Even in the developed regions of the world, the trend seems to be still rising owing to growing vision correction due to factors such as the growing geriatric population. For instance, according to the 2017-18 National Health Survey (NHS) of Australia, the percentage of the population with visual impairment has been rising over the past few years in Australia. This is expected to help the growth of the market.

North America is Expected to Dominate the Market Over the Forecast Period

For contact lenses specifically during COVID-19, with limited social interaction and travel restrictions, the reduction in typical usage occasions has resulted in a decrease in contact lens wear.

The United States and Canada have developed well-structured healthcare systems. These systems also encourage research and development. The supportive government policies are encouraging global market players to enter the United States and Canada. As a result, these countries have the presence of many global market players.

Moreover, a rise in the number of visual inaccuracies is expected to drive the regional market growth. For instance, as per the statistics published by the National Eye Institute, 2019, around 1.3 million Americans are blind and 2.9 million have low vision, and an estimated 2.2 million Americans will be blind and around 5 million Americans will have low vision by 2030. Hence, an increase in eye disorders will lead to a growing demand for contact lenses.

Rising product innovation also bodes well for the regional market growth. For instance, in 2019, Bausch + Lomb announced the US launch of Bausch + Lomb ULTRA Multifocal for Astigmatism contact lenses. In 2020, Alcon Canada strengthened its robust contact lens portfolio in Canada by launching its innovative PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses. Thus, with several developments by companies and demand by customers, the North American region is a highly attractive and stable region for the growth of companies and consumers in the contact lenses market.

Competitive Landscape

The contact lenses market is highly competitive and consists of several major players. The presence of major market players, such as Essilor International SA, Novartis AG, Bausch Health Companies Inc., Zeiss Group, and The Cooper Companies are, in turn, increasing the overall competitive rivalry of the market. With moderate sustainable competitive advantage through innovative products and low competition between online and offline companies, moderate competitive rivalry is observed in this market.

The market participants enter long-term partnerships with suppliers and distributors to gain a competitive advantage and expand their product portfolios and geographical presence.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Increasing Burden of Optical Disorders
    • 4.3.2 Increasing Tendency to Enhance Aesthetics
  • 4.4 Market Restraints
    • 4.4.1 Availability of Alternative Techniques
    • 4.4.2 Complications Associated with Lens
  • 4.5 Industry Attractiveness - Porter's Fives Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Soft Contact Lenses
    • 5.1.2 Hybrid Contact Lenses
    • 5.1.3 Rigid Gas Permeable Contact Lenses
    • 5.1.4 Other Product Types
  • 5.2 By Usage
    • 5.2.1 Corrective Contact Lenses
    • 5.2.2 Therapeutic Contact Lenses
    • 5.2.3 Cosmetic Contact Lenses
    • 5.2.4 Prosthetic Contact Lenses
  • 5.3 By Modality
    • 5.3.1 Conventional
    • 5.3.2 Disposable
  • 5.4 By Design
    • 5.4.1 Spherical
    • 5.4.2 Toric
    • 5.4.3 Multifocal
    • 5.4.4 Other Designs
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 United Kingdom
      • 5.5.2.2 Germany
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Medical Optics Inc.
    • 6.1.2 Alcon Vision LLC
    • 6.1.3 Bausch Health Companies Inc.
    • 6.1.4 Contamac
    • 6.1.5 Essilor International SA
    • 6.1.6 Haohai Biological Technology
    • 6.1.7 Hoya Corporation
    • 6.1.8 Johnson & Johnson Vision Care Inc.
    • 6.1.9 Polylite Sofclear
    • 6.1.10 Scrivens House
    • 6.1.11 Seed Co. Ltd
    • 6.1.12 Novartis AG
    • 6.1.13 SynergEyes Inc.
    • 6.1.14 The Cooper Companies
    • 6.1.15 Zeiss Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS